Close
Nordic 9Nordic 9

p53 Invest (investor - Private Equity)

Norway p53.no
See something wrong or missing? Let us know
Offices:Stavanger

p53 is an investor from Norway that identifies and invests in healthcare companies, particularly in the fields of biotechnology and medical devices.

Average round investment:41.2M USD
Average number per year:1.0
Distribution: 2025 (1)2024 (1)2023 (1)
Portfolio companies: United Kingdom Valink TherapeuticsNorway Calluna PharmaDenmark Teitur Trophics
Mostly invests in: United Kingdom United Kingdom (1) Health services (3)

3 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to p53 Invest

Name Criteria
Ireland Cantor Fitzgerald Private Clients
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Emmanuel Cassimatis
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Kathaka
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Long Ridge Equity Partners
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Faroe Islands Sp/f Framherji
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
China Zhejiang NHU
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Software Services, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Zoubin Ghahramani
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mayo Clinic
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data), Pharma, Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Rosemary Leith
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Software Services, AI (big data), Manufacturing
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States AllegisCyber Capital
92%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B, SAAS
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top